Combined Ibrutinib and Venetoclax for Patients With Chronic Lymphocytic Leukemia

被引：0
|
作者：
不详
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2020年 / 18卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [41] The Use of Ibrutinib in Chronic Lymphocytic Leukemia
    Damon, Lloyd E.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (03) : 154 - 156
  • [42] Risk Model for Overall Survival for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Validated for Patients on Ibrutinib, Idelalisib, Venetoclax, or Chemoimmuniotheraphy
    Soumerai, Jacob D.
    Ni, Ai
    Darif, Mohamed
    Londhe, Anil
    Xing, Guan
    Mun, Yong
    Kay, Neil E.
    Shanafelt, Tait D.
    Chaffee, Kari G.
    Furman, Richard R.
    Hillmen, Peter
    Sharman, Jeff
    Seymour, John F.
    Chanan-Khan, Asher A.
    Byrd, John C.
    Jones, Jeffrey A.
    Ferrante, Lucille A.
    Dreiling, Lyndah K.
    Mobasher, Mehrdad
    Stark, Thomas
    Reddy, Vijay
    Howes, Angela J.
    James, Danelle
    Bhargava, Pankaj
    Zelenetz, Andrew D.
    BLOOD, 2018, 132
  • [43] Detailed Safety Analysis of Venetoclax Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
    Brander, Danielle M.
    Choi, Michael Y.
    Roberts, Andrew W.
    Ma, Shuo
    Lash, L. Leanne
    Verdugo, Maria
    Zhu, Ming
    Kim, Su Young
    Seymour, John F.
    BLOOD, 2016, 128 (22)
  • [44] Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): 4-Year Follow-up Data
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Senapati, Jayastu
    Burger, Jan A.
    Borthakur, Gautam
    Takahashi, Koichi
    Estrov, Zeev E.
    Konopleva, Marina
    Sasaki, Koji
    Kadia, Tapan M.
    Pemmaraju, Naveen
    Daver, Naval
    Jabbour, Elias
    DiNardo, Courtney D.
    Alvarado, Yesid
    Yilmaz, Musa
    Bose, Prithviraj
    Ohanian, Maro
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Nassar, Sameh
    Garg, Naveen
    Hwang, Hyunsoo
    Wang, Xuemei
    Cruz, Nichole
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2022, 140
  • [45] Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): 5-Year Follow-up Data
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Senapati, Jayastu
    Burger, Jan A.
    Borthakur, Gautam
    Swaminathan, Mahesh
    Takahashi, Koichi
    Estrov, Zeev
    Konopleva, Marina Y.
    Sasaki, Koji
    Kadia, Tapan M.
    Pemmaraju, Naveen
    Daver, Naval
    Jabbour, Elias
    DiNardo, Courtney D.
    Valero, Yesid Alvarado
    Yilmaz, Musa
    Bose, Prithviraj
    Ohanian, Maro
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Nassar, Sameh
    Garg, Naveen
    Hwang, Hyunsoo
    Wang, Xuemei
    Cruz, Nichole
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop M.
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2023, 142
  • [46] Venetoclax (VEN) Monotherapy for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapsed after or Were Refractory to Ibrutinib or Idelalisib
    Jones, Jeffrey
    Choi, Michael Y.
    Mato, Anthony R.
    Furman, Richard R.
    Davids, Matthew S.
    Heffner, Leonard T.
    Cheson, Bruce D.
    Lamanna, Nicole
    Barr, Paul M.
    Eradat, Herbert
    Halwani, Ahmad
    Chyla, Brenda
    Zhu, Ming
    Verdugo, Maria
    Humerickhouse, Rod A.
    Potluri, Jalaja
    Wierda, William G.
    Coutre, Steven E.
    BLOOD, 2016, 128 (22)
  • [47] Efficacy and Safety of Ibrutinib in Elderly Patients with Chronic Lymphocytic Leukemia
    Cao, Zhijian
    Ma, Jun
    BLOOD, 2019, 134
  • [48] Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib
    Jain, Preetesh
    Keating, Michael
    Wierda, William
    Estrov, Zeev
    Ferrajoli, Alessandra
    Jain, Nitin
    George, Binsah
    James, Danelle
    Kantarjian, Hagop
    Burger, Jan
    O'Brien, Susan
    BLOOD, 2015, 125 (13) : 2062 - 2067
  • [49] Safety Profile of Venetoclax Monotherapy in Patients with Chronic Lymphocytic Leukemia
    Seymour, John F.
    Davids, Matthew S.
    Roberts, Andrew W.
    Hallek, Michael
    Wierda, William G.
    Hillmen, Peter
    Gerecitano, John F.
    Cerri, Elisa
    Potluri, Jalaja
    Kim, Su Young
    Busman, Todd
    Verdugo, Maria
    Humerickhouse, Rod A.
    Best, Andrea
    Desai, Monali
    Stilgenbauer, Stephan
    BLOOD, 2016, 128 (22)
  • [50] Pharmacokinetics (PK) of ibrutinib in patients with chronic lymphocytic leukemia (CLL)
    Sukbuntherng, Juthamas
    Jejurkar, Purvi
    Chan, Stephen
    Tran, Anh L.
    Moussa, Davina
    James, Danelle Frances
    Loury, David
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345